Walk In interview

Job Title

Tele Sales Officers/Tele sales Executives

Location

Delhi/NCR

Job Descriptions

Outbound Insurance ProcessCalling prospective Clients to generate business sales Making calls to the existing ClientsTele-calling with convincing capability.

Fix meetings for RM with existing as well as prospective Clients

EligibilityQualification UG/ Graduate Good Communication Skills Language Preference English, Hindi, Punjabi

Intersted Candidates can walk in at below Locations

Noida: - 221, Block- D, Sec-63(Near Danik Jagran Building)Contact: Ms.Charu – 9311028811Pusa Road: - 26, Block No-34, 3rd FloorPusa Road, Near karol bagh metro station.Contact: Ms. Simran

Moti Nagar: - 33, DLF Industrial AreaMoti Nagar, Near Moti nagar metro station(Metro Pillar No. 316)Contact: Mr. Amit Arora -9311028812

All the best Team Unicon

Walkin Interview @ UNICON

Job Title

Tele Sales Officers/Tele sales Executives

Location

Delhi/NCR

Job Descriptions

Outbound Insurance Process

Calling prospective Clients to generate business sales

Making calls to the existing Clients

Tele-calling with convincing capability.

Fix meetings for RM with existing as well as prospective Clients

Eligibility

Qualification UG/ Graduate

Good Communication Skills Language Preference English, Hindi, Punjabi

Intersted Candidates can walk in at below Locations

Noida: - 221, Block- D, Sec-63

(Near Danik Jagran Building)

Contact: Ms.Charu – 9311028811

Pusa Road: - 26, Block No-34, 3^rd Floor

Pusa Road, Near karol bagh metro station.

Contact: Ms. Simran

Moti Nagar: - 33, DLF Industrial Area

Moti Nagar, Near Moti nagar metro station

(Metro Pillar No. 316)

Contact: Mr. Amit Arora -9311028812

All the best

Team Unicon

HSIL Ltd - Q2 FY11 Result Update

HSIL Ltd - Q2 FY11 Result Update

o    HSIL Ltd (HSIL)’s total revenue registered a growth of 29% YoY to INR 2220 mn backed by healthy growth in both building products and container glass segments. The results were marginally below our estimates.

o    The company’s operating profit at INR 449 mn, witnessed a 20% increase Y-o-Y. EBITDA margin at 20.84% registered a decrease of 121 basis points on a Y-o-Y basis.

o   PAT at INR 139 mn witnessed a growth of 52% as compared to the same quarter in the previous year. PAT margin at 6.46% has increased by 107 basis points Y-o-Y. EPS for the quarter stood at INR 2.53.

Valuation

At the CMP of INR 137, the stock trades at ~9x our consolidated FY12E EPS. We recommend to “BUY” the stock with a price objective of ~INR 178.

 Thanks & Regards,

Unicon Wealth Research

Banco Products (India) Ltd Q2FY11 Result Update

Banco Products (India) Ltd (BPIL) Q2FY11 Result Update

• BPIL reported a 21.5% YoY increase in standalone revenues to INR 1.2bn for Q2FY11.
• The company registered a decline of 920bps YoY in EBITDA margin to 20.0%.
• The company registered a decline of 910bps YoY in net margin to 12.3%.

Outlook & Valuation

The stock is currently trading at P/E multiple of 6.4x as per our FY12 earnings estimate. We maintain our Buy rating on this stock with a revised target price of INR 149.

Thanks & Regards,

Unicon Wealth Research

Mundra Port & Special Economic Zone Ltd Q2FY11 Result Update

Mundra Port and Special Economic Zone Ltd (MPSEZ) Q2FY11 Result Update

• MPSEZ reported a 26.3% YoY increase in revenues to INR 4.1bn for Q2FY11.
• The company registered a decline of 550bps YoY in EBITDA margin to 66.2% in Q2FY11.
• The company registered a decline of 180bps YoY in net margin to 50.0% in

Outlook & Valuation

The stock is currently trading at a PE multiple of 35x and 28x for FY11 and FY12 respectively as per our earnings estimate. We downgrade our rating from Accumulate to Hold on this stock with a revised target price of INR 175.

Thanks & Regards,

Unicon Wealth Research

Biocon Ltd Q2FY11 Result Update

Biocon Ltd Q2FY11 Result Update

Ø  Biocon registered strong 17% YoY increase in revenues with across-theboard growth in all core businesses like Insulins, Immunosuppressants,

 Statins and Branded Formulations. Quarter revenues increased by ~INR 1 bn to INR 6.8 bn on YoY basis.

Ø  EBITDA increased 27% YoY and 9% QoQ to ~INR 1448 mn in Q2 FY11. EBITDA margin improved by 164 bps to 21.3% on YoY basis, due to

 reduction in operating expense.

Ø  Net Profit also improved by 20.4% YoY and 16.3% QoQ to ~INR 892 mn. Slower growth was seen due to reduction in other income. PAT margin

 improved marginally to 13.1% from 12.8% same period last year.

Outlook & Valuation

Stock is currently trading at 22x its FY12E earnings. We rerate the stock to BUY with a fresh price target of INR 560.

Thanks & Regards,

Unicon Wealth Research

Tata Consultancy Services Ltd Q2FY11 Result Update

Tata Consultancy Services Ltd - Q2FY11 Result Update

Ø  Revenue at INR 92,864 mn; up 25% YoY & 13% sequentially.

Ø  EBITDA was at INR 27,762 mn, up 15% & 31%, QoQ and YoY respectively.

Ø  PAT was at INR 21,990 mn up 32%, YoY and 13%, QoQ.

Outlook & Valuation

Going forward, TCS expects clients to gradually increase their IT budgets. There is also a possibility that pricing could see a little bit of increase going forward. However, attrition remains a concern. With robust demand outlook we expect pricing to improve going forward especially in areas like enterprise solutions, cloud computing & consulting. However, there will be a concern about the uncertainty in global macro environment. With IT spending back and transformational deals making a comeback, TCS looks strong to deliver good performance in the coming quarters. At CMP of INR 986 the stock trades at 24x its FY11e EPS. We raise our price target from INR 1040 to INR 1148. Recommend Accumulate.

Thanks & Regards,

Unicon Wealth Research